Investors Purchase Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) was the recipient of some unusual options trading on Wednesday. Traders bought 1,002 put options on the company. This represents an increase of 1,791% compared to the typical daily volume of 53 put options.

Hedge Funds Weigh In On Maravai LifeSciences

Several institutional investors have recently modified their holdings of MRVI. 12 West Capital Management LP grew its stake in shares of Maravai LifeSciences by 92.2% in the third quarter. 12 West Capital Management LP now owns 6,463,111 shares of the company’s stock worth $64,631,000 after acquiring an additional 3,101,275 shares in the last quarter. Point72 Europe London LLP acquired a new position in shares of Maravai LifeSciences in the fourth quarter worth $17,059,000. Braidwell LP grew its stake in shares of Maravai LifeSciences by 120.3% in the third quarter. Braidwell LP now owns 3,974,857 shares of the company’s stock worth $39,749,000 after acquiring an additional 2,170,157 shares in the last quarter. Mackenzie Financial Corp grew its stake in shares of Maravai LifeSciences by 39.0% in the third quarter. Mackenzie Financial Corp now owns 4,930,841 shares of the company’s stock worth $48,667,000 after acquiring an additional 1,384,455 shares in the last quarter. Finally, Pacer Advisors Inc. grew its stake in shares of Maravai LifeSciences by 37.8% in the fourth quarter. Pacer Advisors Inc. now owns 2,955,230 shares of the company’s stock worth $19,357,000 after acquiring an additional 810,957 shares in the last quarter. Institutional investors and hedge funds own 50.25% of the company’s stock.

Maravai LifeSciences Stock Up 2.7 %

MRVI stock opened at $8.42 on Thursday. Maravai LifeSciences has a one year low of $4.52 and a one year high of $16.62. The company has a debt-to-equity ratio of 0.70, a quick ratio of 7.41 and a current ratio of 8.00. The firm’s 50 day moving average price is $7.89 and its 200-day moving average price is $6.66. The firm has a market cap of $2.12 billion, a PE ratio of -9.36 and a beta of 0.01.

Maravai LifeSciences (NASDAQ:MRVI) last posted its earnings results on Thursday, February 22nd. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.01). Maravai LifeSciences had a negative net margin of 41.19% and a negative return on equity of 1.31%. The company had revenue of $74.14 million during the quarter, compared to analyst estimates of $62.99 million. On average, equities research analysts anticipate that Maravai LifeSciences will post -0.15 EPS for the current year.

Analyst Ratings Changes

MRVI has been the topic of a number of analyst reports. Craig Hallum initiated coverage on Maravai LifeSciences in a research report on Wednesday, April 10th. They set a “buy” rating and a $15.00 target price on the stock. Royal Bank of Canada raised their price target on shares of Maravai LifeSciences from $12.00 to $14.00 and gave the company an “outperform” rating in a research note on Friday, February 23rd. Finally, Stifel Nicolaus decreased their price target on shares of Maravai LifeSciences from $11.00 to $10.00 and set a “buy” rating on the stock in a research note on Friday, February 23rd. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Maravai LifeSciences currently has an average rating of “Moderate Buy” and an average price target of $11.56.

Maravai LifeSciences Company Profile

Maravai LifeSciences Holdings, Inc, a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.